The Winter 2017 edition of the newsletter on SWOG's Lung-MAP precision medicine trial is out. Lung-MAP is NCI's first precision trial, and testing new treatments for squamous cell lung cancer.

The newsletter has the latest on a reopened sub-study, a trial update at the World Conference on Lung Cancer last month in Japan, and a December 7 webinar for site staff, who can get the study status and all their questions answered by Lung-MAP leaders on the call. Read the new edition here.

Other Recent Stories

SWOG Front Line banner
May 15, 2026
Dr. Jonathan W. Friedberg transformed SWOG lymphoma research
SWOG Front Line banner
May 8, 2026
Announced at our spring meeting: The Dr. Charles D. Blanke Veterans’ Access to Clinical Trials Initiative